229,127 Shares in Acadia Healthcare Company, Inc. $ACHC Bought by Clough Capital Partners L P

Clough Capital Partners L P acquired a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 229,127 shares of the company’s stock, valued at approximately $5,359,000. Clough Capital Partners L P owned 0.25% of Acadia Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently added to or reduced their stakes in ACHC. Goldman Sachs Group Inc. boosted its position in shares of Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after acquiring an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. acquired a new position in Acadia Healthcare in the 4th quarter valued at approximately $47,960,000. Wellington Management Group LLP lifted its position in shares of Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after acquiring an additional 2,350,760 shares during the period. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of Acadia Healthcare during the 1st quarter worth approximately $43,017,000. Finally, Invenomic Capital Management LP increased its position in shares of Acadia Healthcare by 71.0% during the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after purchasing an additional 1,375,647 shares during the period.

Acadia Healthcare Price Performance

Shares of ACHC opened at $34.51 on Monday. The business’s fifty day moving average price is $27.64 and its two-hundred day moving average price is $23.24. The firm has a market capitalization of $3.17 billion, a price-to-earnings ratio of -2.82, a PEG ratio of 11.51 and a beta of 0.64. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. The company had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on ACHC shares. Cantor Fitzgerald lifted their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. UBS Group increased their target price on Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. Raymond James Financial upgraded Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research report on Monday, May 4th. Jefferies Financial Group upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price target for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. Finally, Barclays increased their price objective on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 30th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $28.69.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.